Navigation Links
Human Pheromone Sciences Announces Third Quarter Results
Date:11/13/2008

Increase in revenue with reduction in loss for the quarter

SAN JOSE, Calif., Nov. 13 /PRNewswire-FirstCall/ -- Human Pheromone Sciences, Inc. (OTC Bulletin Board: EROX) ("HPS" or "the Company") today announced results for the third quarter and nine months ended September 30, 2008. For the three month period ending September 30, 2008, net revenues of $262,000 represented a 10% increase from the revenues of $239,000 in the prior year period, and resulted in a net loss of $30,000 ($.01 per share) as compared with a net loss of $93,000 ($.02 per share) for the same period of 2007. For the nine month period ending September 30, 2008, net revenues of $764,000 were 15% lower than the previous year's $902,000, resulting in a net loss of $181,000 ($0.04 per share) as compared with a net loss of $54,000 ($0.01 per share) in the first nine months of 2007. At September 30, 2008, the Company reflected a cash balance of $1,082,000 compared with $1,437,000 at December 31, 2007, a $355,000 reduction for the nine months of the current year as compared to a decline of $390,000 during the nine months ending September 30, 2007. There was no bank indebtedness at either date.

A spokesperson indicated "the Company was pleased that its cash utilization was only $355,000 for the first nine months of the year, and that net current liquidity (cash, accounts receivable and inventory, less current liabilities excluding current portion of deferred revenue) decreased only $433,000 for the same nine month period. This lower than expected asset utilization was a result of revenues generated under new licensing agreements, and a concerted effort to only invest in programs that are designed to generate additional future revenues."

"However, we still recognize that the marketing plans of our licensees can create unpredicted volatility of our quarterly performance, and this is not an acceptable posture for the Company in the long-term. We will still continue to nurture
'/>"/>

SOURCE Human Pheromone Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Transdermal Diclofenac enters Phase 1 Clinical Trial in Humans
2. Interleukin Genetics to Present New Findings on Osteoporosis at the 58th Annual Meeting of the American Society of Human Genetics
3. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Deutsche Bank Conference
4. Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments
5. Data to Be Presented at 58th Annual Meeting of The American Society of Human Genetics
6. Ambrx to Present Phase I/II Clinical Data for Optimized, Long Acting Human Growth Hormone Analogue
7. Complete Genomics Chooses Isilon IQ to Power Worlds First Complete Human Genome Sequencing Service
8. Human Genome Sciences to Sponsor Conference Call to Discuss Third Quarter 2008 Financial Results
9. Human Pheromone Sciences, Inc. - Shareholder Update
10. The human brain minimizes energy expenditure and integrates gravity in to the action plan
11. EntreMeds ENMD-2076 Demonstrates Tumor Regression in Human Colon Cancer Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2009)...lif., July 2 Advanced Chemical Tr...es in California, has announced a multi-year partn...third largest Bio-Med company. , , ACT will pro...Materials disposal, vacuum truck services, spill r...anagement support from its corporate headquarters ...
(Date:7/2/2009)... Executes Master Services Agreement Coveri...Solutions , Rochester, Ne...es, Inc., a leader in advanced cardiac safety biom...nced that it has executed a master services agreem...both iCardiac,s Highly Automated QT as well as Dyn...
(Date:7/1/2009)...1 Johnson & Johnson today ...e Department of Molecular Biology at the Max Planc...overies have led to novel cancer therapies includi...he 2009 Dr. Paul Janssen Award for Biomedical Rese...cientists selected Dr. Ullrich, who on September 8...
(Date:7/1/2009)...f investigational sustained follicle stimulant ach...itropin beta given over a one week period in Phase...rstCall/ -- Schering-Plough Corp., (NYSE: SGP ) ...clinical trial demonstrating that a single injecti...sustained follicle stimulants, achieved similar ef...
Breaking Biology Technology:iCardiac Selected by Top 10 Pharmaceutical Company 2Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research 2Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research 3Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research 4Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research 5Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 2Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 3Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 4Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 5Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 6Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 7Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 8Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 9
... Health United signs deal with SBC UW-Stout get...ounces losses for third quarter Badger Meter re...ioscience to move to Research Park Sensient Tec...Health United signs deal with SBC ,The Wisconsin ...ced a three-year deal with communications firm SB...
...ve in interesting times. Not so long ago, we IT pr...pointy hats with stars and moons on them. What we ...ad a whiff of magic. Then like a magic trick gone ... and voila! We were standing in our underwear fo...t, most companies acquired chief information offic...
...son, Wis. Brain drain in Wisconsin, educations e...lified for jobs in the technology industry were a ...ic discussion with the Education Access Panel. , ,... knowledge economy and creating jobs in Wisconsin....Wiley began by citing an article titled Americas ...
...at Nine2Five, we have a lot of lively corresponden...s and, in a few cases, people who are hanging onto...out things that happen in their workplaces. They w...etting promoted and managing a pretty wide range o...t really annoying things that their co-workers and...
Other Biology Technology:Tech Digest: whats moving in the Midwest 2Tech Digest: whats moving in the Midwest 3IT leadership is not just for CIOs anymore 2UW and business leaders outline need for educated workers 2UW and business leaders outline need for educated workers 3Midwest technology bosses should stop flaunting their wealth at work 2Midwest technology bosses should stop flaunting their wealth at work 3Midwest technology bosses should stop flaunting their wealth at work 4
(Date:6/30/2009)...have shown that if elderly men were given growth h...ble muscle mass increase. Dr. Geoff Goldspink (Roy... says: "This raises the question: Can age-related ... ameliorated by the therapeutic application of mec... can also help sufferers of diseases such as muscu...
(Date:6/30/2009)... forest biotechnology to help address significant ...d at birth" by the rigid opposition of some groups...e testing of genetically modified trees, scientist...o create a regulatory environment that considers g...-case basis, and is focused on the end product rat...
(Date:6/30/2009)...f Physics and Astronomy at the University of Leice...has led them to the discovery of fluorescent silic... uptake of drugs by the body,s cells. , Dr Klaus...ew method is the independent control of the nanopa...thod is extremely versatile and produces the fluor...
(Date:6/30/2009)...ver a new discovery which could lead to the single...orysignificantly longer lifespans. The discovery, ... of The FASEB Journal ( http://www.fasebj.org ),...ng-lived bats explains why they live significantly...h as mice. , "Ultimately we are trying to discov...
Breaking Biology News(10 mins):Anti-biotech groups obstruct forest biotechnology 2Anti-biotech groups obstruct forest biotechnology 3University of Leicester researchers discover new fluorescent silicon nanoparticles 2Women in Science fellowship to fund postdocs study of deep sea methane 3668 1Women in Science fellowship to fund postdocs study of deep sea methane 3668 2Women in Science fellowship to fund postdocs study of deep sea methane 3668 3Agilysys Announces Latest Version of Lodging Management System 28R 29 28LMS 29 22097 1Agilysys Announces Latest Version of Lodging Management System 28R 29 28LMS 29 22097 2PA Secretary of Public Welfare Urges General Assembly To Support Saving 24100 Million Through Smarter Pharmacy Benefit Management 22093 1PA Secretary of Public Welfare Urges General Assembly To Support Saving 24100 Million Through Smarter Pharmacy Benefit Management 22093 2PA Secretary of Public Welfare Urges General Assembly To Support Saving 24100 Million Through Smarter Pharmacy Benefit Management 22093 3New Subset Analysis of AndroGel 28R 29 Data Highlights Efficacy Regardless of BMI 2459 1New Subset Analysis of AndroGel 28R 29 Data Highlights Efficacy Regardless of BMI 2459 2New Subset Analysis of AndroGel 28R 29 Data Highlights Efficacy Regardless of BMI 2459 3New Subset Analysis of AndroGel 28R 29 Data Highlights Efficacy Regardless of BMI 2459 4
...respiration in response to higher global temperatu...ken into account plants, ability to adjust to chan... Ridge National Laboratory. , In a Perspectives pa...ony King cites ORNL findings suggesting that about...d soil with the acclimation of plants included in ...
...ed in a cabbage-eating moth may one day provide a ...gene therapy, researchers say. , , They compared...g genes, or transposons, to insert themselves into...s making the cell resistant to damage from radiati... was five to 10 times better than the other circul...
... of California, Los Angeles have defined condition...for years in almost a third of breast cancer survi...Clinical Cancer Research. , The key to their fat...ems. , "These studies identify a biological basi...is implemented by inflammation," said Michael Irwi...
...vestigators at the Center for AIDS Research at Cas...ong with a nationwide team of AIDS/HIV experts, st...role of measurements of the amount of HIV particle...,s ability to fight off the disease. The study, pu...he American Medical Association), indicates that t...
Other Biology News:Plants' role in global warming re-examined 2Jumping gene could provide non-viral alternative for gene therapy 2Jumping gene could provide non-viral alternative for gene therapy 3Inflammation markers identify fatigue in breast cancer survivors 2AIDS study challenges conventional treatment guidelines for HIV patients 2AIDS study challenges conventional treatment guidelines for HIV patients 3
BODIPY FL ATP-Gamma-S binds to ATP-binding proteins. To create this fluorescent nucleotide the BODIPY FL fluorophore was linked through the Gamma-thiol of ATP-Gamma-S. In addition to its potential us
...g information-rich MSn data, the patent-pending Fo...le levels of fragmentation, isotope pattern verifi...es to accurately determine the correct formula for...deducing empirical formulae from mass spec data of...
...a-Genosys offers custom peptide synthesis with a w...ions to best fit your research needs. Purity: I...quence Length: Up to 120 residues Modifications..., phosphorylation, D-amino acids, MAPs, KLH/BSA co...
... 36 mg/L sodium pyruvate, 50 mg/L streptomycin sul...ucose, calcium chloride, and magnesium chloride. T... culture is generally attributed to early workers ...olution of inorganic salts designed to maintain co...
Biology Products: